Contents

Search


ceftazidime-avibactam

Indications: - complicated urinary tract infections - multidrug-resitant Klebsiella pneumoniae resistant to - ceftriaxone, cefepime, imipenem, ciprofloxacin - carbepenem-resistant Enterobacterales [2,3] - complicated intra-abdominal infections

General

antibiotic combination

References

  1. Zuger A The Newest Antibiotics on the Block. NEJM Journal Watch. June 13, 2016 Massachusetts Medical Society (subscription needed) http://www.jwatch.org - Deak D et al. Progress in the fight against multidrug-resistant bacteria? A review of U.S. Food and Drug Administration-approved antibiotics, 2010-2015. Ann Intern Med 2016 May 31 PMID: 27239977
  2. Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025
  3. Tompkins K, van Duin D. Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions. Eur J Clin Microbiol Infect Dis. 2021;40:2053-2068. PMID: 34169446

Components

avibactam ceftazidime (Fortaz, Tazidime, Tazicef)